BackWest Pharmaceutical Services Overview

West Pharmaceutical Services Research & Development

Research & Development expenses for WST.

Quarterly R&D Expenses

$15.80M
3.07% YoY

As of Mar 31, 2026

Annual R&D Expenses (TTM)

$73.80M
8.85% YoY

Trailing 12 months ending Mar 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)